News for Researchers
What Makes Stem Cells into Perfect Allrounders (Phys Org)
(Zurich, Switzerland) University of Zürich researchers have discovered a protein that enables natural embryonic stem cells to form any and all tissue types.
Nature Cell to Unveil Stem Cell Drug for Alzheimer’s Disease in Japan (The Investor)
(Japan) Japan will be the first country to sell a stem cell-based treatment for patients with Alzheimer’s disease.
Cynata Therapeutics Achieves Progress in Stem Cell Technology (Proactive Investors)
(Madison, Wisconsin) Cynata therapeutics received the Notice of Allowance from the US patent office related to their proprietary Cymerus stem cell technology.
Japanese Man is First to Receive Reprogrammed Stem Cells from Another Person (Nature)
(Hyogo, Japan) Creating induced pluripotent stem (IPS) cells from unrelated donors and using them to regenerate tissue/cure diseases has huge possibilities for the future of healthcare.
New Study Sheds Light on Cancer Stem Cell Regulation (Endo Nurse)
(La Jolla, CA) Stem cell signaling process that prevents the formation of intestinal cancers.
Three USC Researchers Receive Grants From California’s Stem Cell Agency (USC News)
(Los Angeles, CA) Three scientists from the USC one grants in excess of $4.3 million or research related to temporary liver patients, animal models for neurodegenerative diseases in the treatment of immune disorders.
Using Stem Cells To Grow New Hair (Eureka Alert)
(La Jolla, CA) Pluripotent stem cells from as a new treatment for hair restoration.
BioTime Announces Issuance of 14 New Patents in the Fields of Regenerative Medicine, Stem Cell Technology, and Cancer Therapy (Digital Journal)
(Alameda, CA) BioTime In announcing the issuance of 14 new patents utilizing pluripotent stem cell technology for therapeutic applications in the field of regenerative medicine.
Orgenesis and Pall Corporation Receive $800,000 Grant From BIRD Foundation for Diabetes Research and Development (CNN)
(White Plains, NY) Orgenesis and PALL Corporation received an $800,000 grant from the Israel Binational Industrial Research and Development (BIRD) Foundation for the development of functional insulin producing cells (IPCs is).